AVITA Medical (RCEL) Operating Leases (2020 - 2025)

AVITA Medical's Operating Leases history runs 6 years deep, the most recent figure standing at $2.1 million for Q4 2025.

• Quarterly Operating Leases fell 24.82% year-over-year to $2.1 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $2.1 million (down 24.82% YoY) and the FY2025 annual result came in at $2.1 million, down 24.82% from the prior year.
• Operating Leases was $2.1 million for Q4 2025 at AVITA Medical, down from $2.3 million in the prior quarter.
• Across five years, Operating Leases topped out at $3.3 million in Q2 2024 and bottomed at $306000.0 in Q4 2022.
• A 5-year average of $1.7 million and a median of $1.7 million in 2021 frame the typical range for Operating Leases.
• Annual changes were most pronounced in 2022 — Operating Leases sank 66.67% — and 2023, when it surged 456.21%.
• AVITA Medical's Operating Leases stood at $918000.0 in 2021, then plunged by 66.67% to $306000.0 in 2022, then jumped by 456.21% to $1.7 million in 2023, then surged by 66.86% to $2.8 million in 2024, then dropped by 24.82% to $2.1 million in 2025.
• Business Quant data shows RCEL's Operating Leases at $2.1 million in Q4 2025, $2.3 million in Q3 2025, and $2.4 million in Q2 2025.